|
120 |
The 3 Phases of QRM – An Inspector's View
|
관리자 |
2025-06-04 |
2,609 |
|
119 |
Addressing Human 'Error' In Pharma Manufacturing
|
관리자 |
2025-06-04 |
1,113 |
|
118 |
The key role of GMP analytical testing for drug products
|
관리자 |
2025-06-04 |
1,277 |
|
117 |
What is Clean in Place (CIP)?
|
관리자 |
2025-06-02 |
2,607 |
|
116 |
The Importance Of Primary And Secondary Drying And Their Impact On Lyophilization
|
관리자 |
2025-04-30 |
2,052 |
|
115 |
Why Pharma Risk Assessments Should Include 'Working Together Alone'
|
관리자 |
2025-04-30 |
1,159 |
|
114 |
When to Replace your HEPA Filter – According to a Cleanroom Expert
|
관리자 |
2025-04-30 |
1,601 |
|
113 |
Why You Need A Raw Material Control Strategy
|
관리자 |
2025-04-30 |
1,046 |
|
112 |
Sterilisation Processes – Requirements and Definitions
|
관리자 |
2025-04-01 |
1,714 |
|
111 |
How to Implement Quality Oversight at Shop Floor Level
|
관리자 |
2025-04-01 |
1,192 |
